Recent studies show that KIF4A-low cervical cancers exhibit greater CNV burden and enrichment of NOTCH1 mutations—features associated with increased neoantigen load and immunotherapy sensitivity. The gene discussed is KIF4A; the disease is cervical carcinoma.